IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production-Reference-Cited by-同舟云学术

IFN-γ activated JAK1 shifts CD40-induced cytokine profiles in human antigen-presenting cells toward high IL-12p70 and low IL-10 production

Published:2010-12 Issue:12 Volume:80 Page:2074-2086
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Conzelmann Michael,Wagner Andreas H.,Hildebrandt Anke,Rodionova Elena,Hess Michael,Zota Annika,Giese Thomas,Falk Christine S.,Ho Anthony D.,Dreger Peter,Hecker Markus,Luft Thomas

Funder

Deutsche Forschungsgemeinschaft

Tumorzentrum Heidelberg-Mannheim

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference42 articles.

1. CD40–CD40 ligand;van Kooten;J Leukoc Biol,2000

2. The TNF receptor superfamily of cellular and viral proteins: activation, costimulation, and death;Smith;Cell,1994

3. The CD40/CD154 receptor/ligand dyad;Schonbeck;Cell Mol Life Sci,2001

4. Cytokine-inducible CD40 expression in human endothelial cells is mediated by interferon regulatory factor-1;Wagner;Blood,2002

5. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help);Lederman;J Exp Med,1992

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. TYK2 in Immune Responses and Treatment of Psoriasis;Journal of Inflammation Research;2022-09

2. Pancreatic cancer is associated with aberrant monocyte function and successive differentiation into macrophages with inferior anti-tumour characteristics;Pancreatology;2021-03

3. IL-10 Signaling in the Tumor Microenvironment of Ovarian Cancer;Advances in Experimental Medicine and Biology;2021

4. TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases;Open Biology;2020-09

5. Downregulation of PTP1B and TC-PTP phosphatases potentiate dendritic cell-based immunotherapy through IL-12/IFNγ signaling;OncoImmunology;2017-06-03